Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BESST: SABER-Bupivacaine for Postoperative Pain
NCT01052012Phase 3Completed
- Sponsor
- DURECT Corporation
- Start
- Dec 2009
- Primary completion
- Sep 2011
- Modality
- Orthosteric Ligands
- Countries
- 3
01
Overview
A Phase 3 trial of bimatoprost in postoperative pain, sponsored by DURECT Corporation. Started Dec 2009; status: completed.
02
Drugs
bimatoprost
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT01052012.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01052012.